For example, breast cancer patients with high tumor SPARC expression were seriously more sensitive to an albumin-bound paclitaxel 22, potentially because of the strong binding capacity of SPARC to albumin, which could lead to the accumulation of paclitaxel in local tumor microenvironment. This evidence concerns the gene ALB and breast carcinoma.